EMYRIA LIMITED - Charts / Financials

0.00%

2.9¢

Market Cap $17.73M

Healthcare Biotechnology

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

REFRESH

Last update - 14.12pm 16/07/2025 (20 minute delay)

Day
Open	3.0¢		Day High	3.1¢		Day Low	2.9¢
Daily Volume	5826648

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	2.9¢	500000		1	3.0¢	100000

Directors & Senior Management

Dr. Michael Gordon Winlo	Managing Director
Ms. Susan Park	Company Secretary
Mr. Greg Hutchinson	Independent Non-Executive Chairman of the Board
Dr. Mohit Kaushal	Non-Executive Director
Dr. Karen L. Smith	Non-Executive Director
Prof. Sir John Tooke	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.9¢		Change 0.000(0.00%)		Mkt cap ! $17.73M

Open	High	Low	Value	Volume
3.0¢	3.1¢	2.9¢	$173.8K	5.826M

Buyers (Bids)

No.	Vol.	Price($)
1	500000	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	500000	0.029
3	138800	0.028
2	41037	0.027
4	91557	0.026
4	640000	0.025

Price($)	Vol.	No.
0.030	180000	3
0.031	450000	2
0.032	92000	1
0.034	216570	3
0.035	159700	3

Last trade - 14.12pm 16/07/2025 (20 minute delay)


Last 2.9¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
2.9¢	3.1¢	2.9¢	704166
Last updated 14.12pm 16/07/2025 ?

EMD (ASX) Chart

EMYRIA LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories